|
WO2001070982A2
(en)
*
|
2000-03-23 |
2001-09-27 |
Immusol Incorporated |
Brca-1 regulators and methods of use
|
|
WO2002008288A2
(en)
*
|
2000-07-20 |
2002-01-31 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO1999060127A2
(en)
|
1998-05-15 |
1999-11-25 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6706262B1
(en)
|
1998-03-18 |
2004-03-16 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
|
US7258860B2
(en)
|
1998-03-18 |
2007-08-21 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US7579160B2
(en)
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
|
US6960570B2
(en)
|
1998-03-18 |
2005-11-01 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
|
US6929938B2
(en)
|
2001-08-15 |
2005-08-16 |
Millennium Pharmaceuticals, Inc. |
25501, a human transferase family member and uses therefor
|
|
US7141417B1
(en)
|
1999-02-25 |
2006-11-28 |
Thomas Jefferson University |
Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene
|
|
EP1163252A4
(en)
*
|
1999-02-25 |
2004-04-07 |
Univ Jefferson |
Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
|
|
WO2000050458A1
(en)
*
|
1999-02-26 |
2000-08-31 |
Smithkline Beecham Corporation |
Cloning of a p2y-like 7tm receptor (axor17)
|
|
JP2004506402A
(en)
*
|
1999-03-23 |
2004-03-04 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
48 human secretory proteins
|
|
WO2000058480A1
(en)
|
1999-03-29 |
2000-10-05 |
Kansai Technology Licensing Organization Co., Ltd. |
Novel cytidine deaminase
|
|
EP1637541B1
(en)
*
|
1999-09-01 |
2010-03-03 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
AU1238201A
(en)
*
|
1999-10-27 |
2001-05-08 |
Millennium Pharmaceuticals, Inc. |
Novel molecules and the card-related protein family and uses thereof
|
|
US6893818B1
(en)
|
1999-10-28 |
2005-05-17 |
Agensys, Inc. |
Gene upregulated in cancers of the prostate
|
|
US7005499B1
(en)
*
|
1999-11-18 |
2006-02-28 |
Genentech, Inc. |
Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
|
|
EP1878794A3
(en)
*
|
1999-11-30 |
2008-01-23 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
CA2491610A1
(en)
*
|
1999-12-01 |
2001-06-07 |
Kevin P. Baker |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
CN1300781A
(en)
*
|
1999-12-22 |
2001-06-27 |
上海博德基因开发有限公司 |
Polypeptide-human SHC protein 43 and polynucleotide for coding this polypeptide
|
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
|
WO2001055391A2
(en)
|
2000-01-26 |
2001-08-02 |
Agensys, Inc |
84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
|
|
US6953682B2
(en)
|
2000-02-10 |
2005-10-11 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor
|
|
US20020082212A1
(en)
*
|
2000-07-20 |
2002-06-27 |
Millennium Pharmaceuticals, Inc. |
7716, a novel human ATPase and uses therefor
|
|
US7078205B2
(en)
|
2000-02-17 |
2006-07-18 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor
|
|
US20020031815A1
(en)
*
|
2000-06-26 |
2002-03-14 |
Millennium Pharmaceuticals, Inc. |
46619, a novel human beta-ketoacyl synthase and uses thereof
|
|
US20020055159A1
(en)
*
|
2000-06-15 |
2002-05-09 |
Meyers Rachel A. |
23680,a novel human aminotransferase and uses therefor
|
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
|
US20020025931A1
(en)
|
2000-03-24 |
2002-02-28 |
Rachel Meyers |
3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
|
|
US20030198953A1
(en)
*
|
2000-03-30 |
2003-10-23 |
Spytek Kimberly A. |
Novel proteins and nucleic acids encoding same
|
|
US7632929B2
(en)
|
2000-04-20 |
2009-12-15 |
The Board Of Trustees Of The University Of Arkansas |
Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
|
|
CA2407044A1
(en)
|
2000-04-25 |
2001-11-01 |
Lexicon Genetics Incorporated |
Novel human kinase proteins and polynucleotides encoding the same
|
|
AU2001257407A1
(en)
*
|
2000-04-26 |
2001-11-07 |
Millennium Pharmaceuticals, Inc. |
21657, a human short-chain dehydrogenase and uses thereof
|
|
US6808876B1
(en)
|
2000-05-02 |
2004-10-26 |
Immusol, Inc. |
Cellular regulators of infectious agents and methods of use
|
|
EP1278863A2
(en)
*
|
2000-05-12 |
2003-01-29 |
MERCK PATENT GmbH |
Human serine-threonine kinase-4
|
|
US20040175815A1
(en)
*
|
2000-05-26 |
2004-09-09 |
Yonghong Xiao |
Regulation of human p78-like serube/threonine kinase
|
|
EP1158001B1
(en)
*
|
2000-05-26 |
2007-11-14 |
F. Hoffmann-La Roche Ag |
A nucleic acid which is upregulated in human tumor cells, a protein encoded thereby and a process for tumor diagnosis
|
|
DE10027170A1
(en)
*
|
2000-05-31 |
2001-12-13 |
Schering Ag |
Human PEM as a target for fertility control
|
|
AU6531101A
(en)
*
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2001093805A2
(en)
*
|
2000-06-02 |
2001-12-13 |
The Brigham & Women's Hospital, Inc. |
FUSION OF jAZF1 AND jjAZ1 GENES IN ENDOMETIRIAL STROMAL TUMORS
|
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2001094385A2
(en)
*
|
2000-06-05 |
2001-12-13 |
Bayer Aktiengesellschaft |
Human hm74-like g protein coupled receptor
|
|
US6323016B1
(en)
|
2000-06-09 |
2001-11-27 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
|
EP1287029A2
(en)
*
|
2000-06-09 |
2003-03-05 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
|
CA2409315A1
(en)
*
|
2000-06-16 |
2001-12-20 |
Incyte Genomics, Inc. |
Protein phosphatases
|
|
EP2075253A1
(en)
*
|
2000-06-23 |
2009-07-01 |
Genentech, Inc. |
Compositions and methds for the diagnosis and treatment of disorders involving angiogensis
|
|
EP1309684A2
(en)
*
|
2000-06-27 |
2003-05-14 |
Curagen Corporation |
Polynucleotides and polypeptides encoded thereby
|
|
US7094587B2
(en)
|
2000-06-27 |
2006-08-22 |
Millennium Pharmaceuticals, Inc. |
16002 Molecules and uses therefor
|
|
AU2001271621A1
(en)
|
2000-06-28 |
2002-01-08 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating colon cancer
|
|
US6900303B2
(en)
|
2000-06-30 |
2005-05-31 |
Millennium Pharmaceuticals, Inc. |
57658, a novel human uridine kinase and uses thereof
|
|
WO2002004510A2
(en)
*
|
2000-07-07 |
2002-01-17 |
Incyte Genomics, Inc. |
Gtp-binding proteins
|
|
WO2002004520A2
(en)
*
|
2000-07-07 |
2002-01-17 |
Incyte Genomics, Inc. |
Transporters and ion channels
|
|
WO2002006326A2
(en)
*
|
2000-07-14 |
2002-01-24 |
Millennium Pharmaceuticals, Inc. |
62088, a human nucleoside phosphatase family member and uses thereof
|
|
AU2001281967A1
(en)
*
|
2000-07-18 |
2002-01-30 |
Bayer Aktiengesellschaft |
Regulation of human desc1-like serine protease
|
|
WO2002006318A2
(en)
*
|
2000-07-18 |
2002-01-24 |
Board Of Regents, The University Of Texas System |
Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells
|
|
CA2418198A1
(en)
*
|
2000-07-25 |
2002-01-31 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Novel protein containing ring finger domaine r1p4
|
|
WO2002008281A2
(en)
*
|
2000-07-26 |
2002-01-31 |
Stanford University |
Bstp-cad protein and related reagents and methods of use thereof
|
|
WO2002008282A2
(en)
*
|
2000-07-26 |
2002-01-31 |
Stanford University |
Bstp-ras/rerg protein and related reagents and methods of use thereof
|
|
EP1657254A3
(en)
*
|
2000-08-01 |
2006-06-07 |
Genentech, Inc. |
Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer
|
|
US7335732B2
(en)
|
2000-08-01 |
2008-02-26 |
Genentech, Inc. |
PRO9799 polypeptides
|
|
EP1307557A2
(en)
|
2000-08-02 |
2003-05-07 |
The Johns Hopkins University |
Endothelial cell expression patterns
|
|
EP1315431A1
(en)
*
|
2000-08-02 |
2003-06-04 |
Millennium Pharmaceuticals, Inc. |
A human gtp-releasing factor family member (15368) and uses therefor
|
|
WO2002012330A2
(en)
*
|
2000-08-04 |
2002-02-14 |
Zymogenetics, Inc. |
Human secreted protein, zzp1
|
|
WO2002012285A2
(en)
*
|
2000-08-10 |
2002-02-14 |
Board Of Regents, The University Of Texas System |
The tumor suppressor car-1
|
|
WO2002014355A2
(en)
*
|
2000-08-11 |
2002-02-21 |
Merck Patent Gmbh |
Novel mitogen activated kinase
|
|
EP1326985A1
(en)
*
|
2000-08-18 |
2003-07-16 |
MERCK PATENT GmbH |
Identification of a human n-terminal acetyltransferase gene
|
|
WO2002016586A2
(en)
*
|
2000-08-21 |
2002-02-28 |
Bristol-Myers Squibb Company |
Adenosine deaminase homolog
|
|
JP2004519217A
(en)
*
|
2000-08-21 |
2004-07-02 |
インサイト・ゲノミックス・インコーポレイテッド |
Microtubule-associated proteins and tubulin
|
|
AU2001284655A1
(en)
*
|
2000-08-24 |
2002-03-04 |
Eli Lilly And Company |
Nucleic acids, vectors, host cells, polypeptides and uses thereof
|
|
CA2705366A1
(en)
|
2000-08-28 |
2002-03-07 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
|
|
EP1313761A4
(en)
*
|
2000-08-28 |
2005-01-26 |
Human Genome Sciences Inc |
18 human secreted proteins
|
|
WO2002018568A2
(en)
*
|
2000-08-28 |
2002-03-07 |
Astrazeneca Ab |
Molecules involved in the regulation of insulin in resistance syndrome (irs)
|
|
AU2001286815A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Millennium Pharmaceuticals, Inc. |
48921, a novel human gtp releasing factor and uses therefor
|
|
WO2002018573A2
(en)
*
|
2000-08-30 |
2002-03-07 |
Millennium Pharmaceuticals, Inc. |
54370, a novel human sulfate transporter and uses therefor
|
|
AU2002210464A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Bayer Aktiengesellschaft |
Regulation of human aminotransferase-like enzyme
|
|
WO2002018552A2
(en)
*
|
2000-08-30 |
2002-03-07 |
Bayer Aktiengesellschaft |
Regulation of human aminotransferase-like enzyme
|
|
AU2001288600A1
(en)
|
2000-08-31 |
2002-03-13 |
Millennium Pharmaceuticals, Inc. |
62112, a novel human dehydrogenase and uses thereof
|
|
ATE431405T1
(en)
|
2000-09-05 |
2009-05-15 |
Amgen Inc |
TNF RECEPTOR-LIKE MOLECULES AND THEIR APPLICATIONS
|
|
EP1364015A2
(en)
*
|
2000-09-05 |
2003-11-26 |
Incyte Genomics, Inc. |
Molecules for diagnostics and therapeutics
|
|
WO2002020765A2
(en)
*
|
2000-09-08 |
2002-03-14 |
Millennium Pharmaceuticals, Inc. |
38646, a guanine nucleotide exchange factor and uses therefor
|
|
US6372468B1
(en)
*
|
2000-09-14 |
2002-04-16 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
|
US6391606B1
(en)
*
|
2000-09-14 |
2002-05-21 |
Pe Corporation |
Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
|
|
WO2002029058A2
(en)
*
|
2000-10-05 |
2002-04-11 |
Curagen Corporation |
Human proteins, polynucleotides encoding them and methods of using the same
|
|
AU2002211597A1
(en)
*
|
2000-10-11 |
2002-04-22 |
Millennium Pharmaceuticals, Inc. |
8843, a human dual specificity phosphatase family member and uses therefor
|
|
AU2002220613A1
(en)
*
|
2000-10-11 |
2002-04-22 |
Bayer Aktiengesellschaft |
Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase
|
|
US20020064831A1
(en)
*
|
2000-10-12 |
2002-05-30 |
The Texas A&M University System |
Nucleic acid sequences encoding CMG proteins, CMG proteins, and methods for their use
|
|
WO2002030268A2
(en)
*
|
2000-10-13 |
2002-04-18 |
Eos Biotechnology, Inc. |
Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
|
|
US6531297B2
(en)
*
|
2000-10-20 |
2003-03-11 |
Applera Corporation |
Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
|
|
AU2002249787A1
(en)
|
2000-10-25 |
2002-08-19 |
Diadexus, Inc. |
Compositions and methods relating to lung specific genes and proteins
|
|
WO2002036781A2
(en)
*
|
2000-10-31 |
2002-05-10 |
Bayer Aktiengesellschaft |
Regulation of human glutathione-s-transferase
|
|
WO2002038743A2
(en)
*
|
2000-11-09 |
2002-05-16 |
Glaxo Group Limited |
Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
|
|
US6855517B2
(en)
|
2000-11-20 |
2005-02-15 |
Diadexus, Inc. |
Compositions and methods relating to breast specific genes and proteins
|
|
WO2002081667A2
(en)
*
|
2000-12-05 |
2002-10-17 |
Incyte Genomics, Inc. |
Ligases
|
|
US7776523B2
(en)
|
2000-12-07 |
2010-08-17 |
Novartis Vaccines And Diagnostics, Inc. |
Endogenous retroviruses up-regulated in prostate cancer
|
|
WO2002046417A2
(en)
|
2000-12-07 |
2002-06-13 |
Zymogenetics, Inc. |
Adipocyte complement related protein zacrp3x2
|
|
AU2002211305A1
(en)
*
|
2000-12-14 |
2002-06-24 |
Pe Corporation (Ny) |
Isolated human kinase proteins, their encoding nucleic acid molecules, and uses thereof
|
|
US20020142376A1
(en)
*
|
2000-12-20 |
2002-10-03 |
Gennady Merkulov |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
|
US7892730B2
(en)
*
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
|
CA2432867A1
(en)
|
2000-12-22 |
2002-08-08 |
Bristol-Myers Squibb Company |
A novel human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1
|
|
US6423521B1
(en)
|
2000-12-28 |
2002-07-23 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
|
WO2002053591A1
(en)
*
|
2000-12-30 |
2002-07-11 |
Lion Bioscience Ag |
Mammalian nuclear receptor cofactor cf12 and methods of use
|
|
WO2002053754A2
(en)
*
|
2001-01-08 |
2002-07-11 |
Lexicon Genetics Incorporated |
Human protease and polynucleotides encoding the same
|
|
WO2002061046A2
(en)
*
|
2001-01-30 |
2002-08-08 |
Regeneron Pharmaceuticals, Inc. |
Novel nucleic acid and polypeptide molecules
|
|
EP1409536A2
(en)
*
|
2001-02-12 |
2004-04-21 |
Curagen Corporation |
Human proteins and nucleic acids encoding same
|
|
EP1637601A3
(en)
*
|
2001-02-21 |
2006-03-29 |
Curagen Corporation |
Proteins, polynucleotides encoding them and methods of using the same
|
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
|
WO2002074906A2
(en)
*
|
2001-03-16 |
2002-09-26 |
Eli Lilly And Company |
Lp mammalian proteins; related reagents
|
|
US6913904B2
(en)
*
|
2001-03-27 |
2005-07-05 |
Applera Corporation |
Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
|
|
AU2002258626B2
(en)
|
2001-04-10 |
2007-01-18 |
Agensys, Inc. |
Nucleid acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
|
|
ATE512216T1
(en)
|
2001-04-10 |
2011-06-15 |
Agensys Inc |
NUCLEIC ACID AND THIS CORRESPONDING PROTEIN, CALLED 184P1E2, SUITABLE FOR THE TREATMENT AND DETECTION OF CANCER
|
|
EP2280030A3
(en)
|
2001-04-10 |
2011-06-15 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
WO2002088175A1
(en)
*
|
2001-04-24 |
2002-11-07 |
Otsuka Pharmaceutical Co., Ltd. |
Crohn's disease antibody-binding peptide and method of examining crohn's disease
|
|
CA2483507A1
(en)
*
|
2001-04-24 |
2002-10-31 |
Isis Innovation Limited |
Enzyme and snp marker for disease
|
|
WO2002090546A1
(en)
*
|
2001-05-07 |
2002-11-14 |
Shionogi & Co., Ltd. |
Polypeptide serving as angiogenic marker and dna thereof
|
|
WO2002090543A2
(en)
*
|
2001-05-09 |
2002-11-14 |
Bayer Aktiengesellschaft |
Regulation of human phosphatidic acid phosphatase type 2c-like protein
|
|
US7235358B2
(en)
*
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
|
AU2002311535A1
(en)
*
|
2001-06-26 |
2003-01-08 |
Decode Genetics Ehf. |
Nucleic acids encoding protein kinases
|
|
US20030120040A1
(en)
|
2001-06-29 |
2003-06-26 |
Genentech, Inc. |
Secreted and Transmembrane polypeptides and nucleic acids encoding the same
|
|
GB2399086A
(en)
*
|
2001-08-02 |
2004-09-08 |
Aeomica Inc |
Human zinc finger containing gene MDZ4
|
|
EP1423415A4
(en)
*
|
2001-08-17 |
2005-04-06 |
Incyte Genomics Inc |
Intracellular signaling molecules
|
|
US7270960B2
(en)
|
2001-08-29 |
2007-09-18 |
Pacific Northwest Research Institute |
Diagnosis of ovarian carcinomas
|
|
WO2003023063A1
(en)
*
|
2001-09-07 |
2003-03-20 |
Sankyo Company, Limited |
Method of judging onset risk of diabetes
|
|
WO2003040369A2
(en)
*
|
2001-09-17 |
2003-05-15 |
Molecular Engines Laboratories |
Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines
|
|
WO2003025175A2
(en)
*
|
2001-09-17 |
2003-03-27 |
Molecular Engines Laboratories |
Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
|
|
CA2417455C
(en)
|
2001-09-28 |
2008-01-29 |
Brigham Young University |
Novel cyclooxygenase variants and methods of use
|
|
US20040248132A1
(en)
|
2001-10-04 |
2004-12-09 |
Toshiyuki Sakai |
DR5 gene promoter and siah-1 gene promoter
|
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
|
WO2003031607A1
(en)
*
|
2001-10-10 |
2003-04-17 |
Bayer Healthcare Ag |
Regulation of human short-chain dehydrogenase/reductase
|
|
ATE364690T1
(en)
|
2001-11-09 |
2007-07-15 |
Proteologics Inc |
POSH NUCLEIC ACID, POLYPEPTIDES AND RELATED METHODS
|
|
US7491690B2
(en)
|
2001-11-14 |
2009-02-17 |
Northwestern University |
Self-assembly and mineralization of peptide-amphiphile nanofibers
|
|
WO2003044197A1
(en)
*
|
2001-11-21 |
2003-05-30 |
Japan Science And Technology Agency |
Huntington’s disease gene transcriptional factors
|
|
US7151162B2
(en)
|
2001-12-06 |
2006-12-19 |
The University Of Children's Hospital Of Both Cantons Of Basel |
Nuclear protein
|
|
AU2002339697A1
(en)
*
|
2001-12-19 |
2003-06-30 |
Genset S.A. |
Gmg-5 polynucleotides and polypeptides and uses thereof
|
|
JP2003245084A
(en)
*
|
2001-12-20 |
2003-09-02 |
Morinaga Milk Ind Co Ltd |
New gene useful for diagnosis and treatment of aplasia of corpus callosum and aspermatogenesis and use thereof
|
|
DE10163467A1
(en)
*
|
2001-12-21 |
2003-11-27 |
Axaron Bioscience Ag |
New DNA sequence encoding protein 24B2, useful for treatment and diagnosis or cancer and degenerative diseases, also related polypeptides and modulators
|
|
US6759222B2
(en)
|
2002-01-02 |
2004-07-06 |
Millennium Pharmaceuticals, Inc. |
14815, a human kinase family member and uses therefor
|
|
AU2003202543A1
(en)
*
|
2002-01-07 |
2003-07-24 |
Bayer Aktiengesellschaft |
Human phosphatidic acid phosphatase type 2-like protein
|
|
AU2003205611A1
(en)
*
|
2002-01-15 |
2003-07-30 |
Medigene Ag |
Dilated cardiomyopathy associated gene-2 (dcmag-2): a cytoplasmatic inducer of sarcomeric remodeling in cardiomyocytes
|
|
WO2003060109A2
(en)
*
|
2002-01-15 |
2003-07-24 |
Bayer Healthcare Ag |
Human subtilisin/kexin-like convertase
|
|
JPWO2003062429A1
(en)
*
|
2002-01-23 |
2005-05-26 |
山之内製薬株式会社 |
New serine protease
|
|
US7371719B2
(en)
|
2002-02-15 |
2008-05-13 |
Northwestern University |
Self-assembly of peptide-amphiphile nanofibers under physiological conditions
|
|
EP1338609A1
(en)
*
|
2002-02-21 |
2003-08-27 |
MEMOREC Stoffel GmbH-Medizinisch-Molekulare Entwicklung, Köln |
A further KDR receptor and the use thereof
|
|
CA2478271A1
(en)
*
|
2002-03-05 |
2003-09-18 |
Applera Corporation |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
|
AU2003208472A1
(en)
*
|
2002-03-06 |
2003-09-16 |
Oxford Glycosciences (Uk) Ltd |
Novel b-cell malignancy-associated protein
|
|
DK2261369T3
(en)
|
2002-03-13 |
2014-07-28 |
Genomic Health Inc |
Gene expression profiling in tumor tissue biopsies
|
|
JP3949111B2
(en)
*
|
2002-03-19 |
2007-07-25 |
田辺製薬株式会社 |
Novel G protein-coupled receptor and gene thereof
|
|
US7527935B2
(en)
|
2002-03-19 |
2009-05-05 |
Mitsubishi Tanabe Pharma Corporation |
G-protein coupled receptor having eicosanoid as ligand and gene thereof
|
|
GB0206684D0
(en)
*
|
2002-03-21 |
2002-05-01 |
Babraham Inst |
Novel proteins
|
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
|
US7329502B2
(en)
|
2002-04-25 |
2008-02-12 |
The United States Of America As Represented By The Department Of Health And Human Services |
ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
|
|
JP2004041003A
(en)
*
|
2002-05-17 |
2004-02-12 |
Takeda Chem Ind Ltd |
New protein, its dna and use thereof
|
|
EP2275118A3
(en)
|
2002-05-29 |
2011-10-19 |
DeveloGen Aktiengesellschaft |
Pancreas-specific proteins
|
|
US7198899B2
(en)
|
2002-06-03 |
2007-04-03 |
Chiron Corporation |
Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
|
|
BRPI0311822B8
(en)
|
2002-06-06 |
2021-05-25 |
Oncotherapy Science Inc |
pharmaceutical composition for the treatment of cancer
|
|
AU2003276679A1
(en)
|
2002-06-13 |
2003-12-31 |
Chiron Corporation |
Vectors for expression of hml-2 polypeptides
|
|
JPWO2004009626A1
(en)
*
|
2002-07-22 |
2005-11-17 |
アステラス製薬株式会社 |
Rheumatoid arthritis-related novel gene
|
|
EP1551976B1
(en)
|
2002-08-14 |
2008-12-31 |
National Institue of Advanced Industrial Science and Technology |
Novel n-acetylgalactosamine transferases and nucleic acids encoding the same
|
|
AU2003243151A1
(en)
*
|
2002-08-16 |
2004-03-03 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
|
WO2004018518A1
(en)
*
|
2002-08-23 |
2004-03-04 |
Japan Science And Technology Agency |
Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof
|
|
WO2004020662A2
(en)
*
|
2002-08-27 |
2004-03-11 |
Epigenomics Ag |
Method and nucleic acids for the analysis of breast cell proliferative disorders
|
|
US7452969B2
(en)
|
2002-08-30 |
2008-11-18 |
Licentia Ltd |
Neurotrophic factor protein and uses thereof
|
|
ES2320443T3
(en)
*
|
2002-09-30 |
2009-05-22 |
Oncotherapy Science, Inc. |
GENES AND POLYPEPTIDES RELATED TO HUMAN PANCREATIC CANCERS.
|
|
AU2003294696A1
(en)
*
|
2002-10-17 |
2004-05-04 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylytransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases
|
|
AU2002952216A0
(en)
*
|
2002-10-23 |
2002-11-07 |
The Walter And Eliza Hall Institute Of Medical Research |
Novel therapeutic molecules
|
|
US7554021B2
(en)
|
2002-11-12 |
2009-06-30 |
Northwestern University |
Composition and method for self-assembly and mineralization of peptide amphiphiles
|
|
AU2003295598B2
(en)
|
2002-11-15 |
2009-12-24 |
Genomic Health, Inc. |
Gene expression profiling of EGFR positive cancer
|
|
DE10254601A1
(en)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Gene products differentially expressed in tumors and their use
|
|
AU2002953341A0
(en)
*
|
2002-12-13 |
2003-01-09 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
|
AU2003287764B2
(en)
*
|
2002-12-13 |
2010-01-21 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
|
WO2004070025A2
(en)
*
|
2003-02-05 |
2004-08-19 |
Juan Saus |
Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
|
|
EP1445614A1
(en)
*
|
2003-02-06 |
2004-08-11 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
A method for the in vitro assessment of the progression status of an HIV virus in an invidual
|
|
US7074891B2
(en)
|
2003-02-07 |
2006-07-11 |
Posco |
Leukocyte stimulating peptides
|
|
ES2314378T3
(en)
|
2003-02-20 |
2009-03-16 |
Genomic Health, Inc. |
USE OF INTRONIC RNA TO MEASURE GENE EXPRESSION.
|
|
CA2517953A1
(en)
*
|
2003-03-04 |
2004-09-16 |
Astellas Pharma Inc. |
Novel gene relating to fibrotic conditions
|
|
PL2248899T3
(en)
|
2003-03-19 |
2015-10-30 |
Biogen Ma Inc |
NOGO receptor binding protein
|
|
ITRM20030149A1
(en)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
ANTISENSE OLIGONUCLEOTIDES (ODN) FOR SMAD7 AND THEIR USE IN THE MEDICAL FIELD
|
|
CA3061769C
(en)
|
2003-06-24 |
2021-10-26 |
Genomic Health, Inc. |
Methods of predicting the likelihood of long-term survival of a human patient with node-negative, estrogen receptor (er) positive, invasive ductal breast cancer without the recurrence of breast cancer
|
|
DK1644858T3
(en)
|
2003-07-10 |
2018-01-22 |
Genomic Health Inc |
Functional clothing with at least one outer layer and inner membrane.
|
|
EP2311468B1
(en)
|
2003-08-08 |
2014-01-15 |
Perseus Proteomics Inc. |
Gene overexpressed in cancer
|
|
US20050136434A1
(en)
*
|
2003-08-12 |
2005-06-23 |
Mai Xu |
Isolated heat-inducible cell surface protein and hyperthermia-based tumor immunotargeting therapy
|
|
US20070178458A1
(en)
*
|
2003-09-05 |
2007-08-02 |
O'brien Philippa |
Methods of diagnosis and prognosis of ovarian cancer II
|
|
WO2005026314A2
(en)
*
|
2003-09-10 |
2005-03-24 |
Japan Science And Technology Agency |
Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same
|
|
DE602004028262D1
(en)
*
|
2003-10-02 |
2010-09-02 |
Glaxosmithkline Biolog Sa |
B. PERTUSSIS ANTIGENE AND ITS USE IN VACCINATION
|
|
BRPI0414924A
(en)
|
2003-10-03 |
2006-11-07 |
Brigham & Womens Hospital |
tim-3 ligands and their methods
|
|
WO2005040791A2
(en)
*
|
2003-10-21 |
2005-05-06 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with somatostatin- and angiogenin-like peptide receptor (salpr)
|
|
US20050255560A1
(en)
*
|
2003-11-21 |
2005-11-17 |
Zeren Gao |
Ztnf11, a tumor necrosis factor
|
|
US7544661B2
(en)
*
|
2003-12-05 |
2009-06-09 |
Northwestern University |
Self-assembling peptide amphiphiles and related methods for growth factor delivery
|
|
DE602004031368D1
(en)
|
2003-12-23 |
2011-03-24 |
Genomic Health Inc |
UNIVERSAL REPRODUCTION OF FRAGMENTED RNA
|
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
|
EP3556866B1
(en)
*
|
2004-03-02 |
2021-04-07 |
The Johns Hopkins University |
Mutations of the pik3ca gene in human cancers
|
|
TW200539890A
(en)
|
2004-03-12 |
2005-12-16 |
Brigham & Womens Hospital |
Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
|
|
WO2005090569A1
(en)
*
|
2004-03-24 |
2005-09-29 |
The Council Of The Queensland Institute Of Medical Research |
Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof
|
|
KR101204286B1
(en)
*
|
2004-03-30 |
2012-11-26 |
엔에스진 에이/에스 |
Therapeutic use of a growth factor, NsG33
|
|
WO2005100606A2
(en)
|
2004-04-09 |
2005-10-27 |
Genomic Health, Inc. |
Gene expression markers for predicting response to chemotherapy
|
|
DE102004024617A1
(en)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentially expressed in tumors gene products and their use
|
|
WO2005118832A2
(en)
*
|
2004-06-01 |
2005-12-15 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase-like protein (sgkl)
|
|
ES2395094T3
(en)
|
2004-06-24 |
2013-02-08 |
Biogen Idec Ma Inc. |
Treatment of conditions that involve demyelination
|
|
US7587279B2
(en)
|
2004-07-06 |
2009-09-08 |
Genomic Health |
Method for quantitative PCR data analysis system (QDAS)
|
|
WO2006013661A1
(en)
*
|
2004-08-05 |
2006-02-09 |
Toagosei Co., Ltd. |
Crohn’s disease antibody epitope peptide and reagent for testing crohn’s disease
|
|
US7622251B2
(en)
|
2004-11-05 |
2009-11-24 |
Genomic Health, Inc. |
Molecular indicators of breast cancer prognosis and prediction of treatment response
|
|
AU2005304824B2
(en)
|
2004-11-05 |
2011-12-22 |
Genomic Health, Inc. |
Predicting response to chemotherapy using gene expression markers
|
|
EP2325207B1
(en)
|
2004-11-12 |
2017-03-15 |
Xencor, Inc. |
FC variants with altered binding to FCRN
|
|
US8367805B2
(en)
|
2004-11-12 |
2013-02-05 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
JP2008531733A
(en)
|
2005-03-04 |
2008-08-14 |
ノースウエスタン ユニバーシティ |
Angiogenic heparin-binding epitopes, peptide amphiphiles, self-assembling compositions, and related uses
|
|
US8497101B2
(en)
*
|
2005-05-13 |
2013-07-30 |
Centre National De La Recherche Scientifique (Cnrs) |
Use of a new gene coding for a new member of the MCM2-8 family in pharmaceutical compositions
|
|
PL1904104T3
(en)
|
2005-07-08 |
2014-02-28 |
Biogen Ma Inc |
Sp35 antibodies and uses thereof
|
|
WO2007014338A2
(en)
*
|
2005-07-26 |
2007-02-01 |
Siemens Medical Solutions Diagnostics |
Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease
|
|
US8207128B2
(en)
*
|
2005-09-28 |
2012-06-26 |
Supadelixir Inc. |
Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
CA2633468C
(en)
|
2005-12-14 |
2014-02-18 |
Licentia Ltd |
Novel neurotrophic factor protein and uses thereof
|
|
JP2009540852A
(en)
*
|
2006-07-03 |
2009-11-26 |
エグゾニ・テラピューティック・ソシエテ・アノニム |
Prostate-specific transcripts and their use in the treatment and diagnosis of prostate cancer
|
|
US20080108070A1
(en)
*
|
2006-09-08 |
2008-05-08 |
Corixa Corporation |
Methods, compositions, and kits for the detection and monitoring of colon cancer
|
|
US8076295B2
(en)
|
2007-04-17 |
2011-12-13 |
Nanotope, Inc. |
Peptide amphiphiles having improved solubility and methods of using same
|
|
US8999634B2
(en)
*
|
2007-04-27 |
2015-04-07 |
Quest Diagnostics Investments Incorporated |
Nucleic acid detection combining amplification with fragmentation
|
|
GB0805159D0
(en)
*
|
2008-03-19 |
2008-04-23 |
Sancho Madrid David |
Immune modulation via C-type lectin
|
|
ES2555282T3
(en)
*
|
2007-07-27 |
2015-12-30 |
Immatics Biotechnologies Gmbh |
New immunogenic epitopes for immunotherapy
|
|
US7863021B2
(en)
|
2007-09-05 |
2011-01-04 |
Celera Corporation |
Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
|
|
WO2009034661A1
(en)
*
|
2007-09-12 |
2009-03-19 |
Toppan Printing Co., Ltd. |
Method for diagnosis and induction of resistance to virus
|
|
ES2401233T3
(en)
|
2007-10-17 |
2013-04-18 |
Universidad de Córdoba |
Isoforms of the human somatostatin type 5 receptor produced by alternative treatment and oligonucleotide pairs for their detection by PCR
|
|
EP2808343B8
(en)
|
2007-12-26 |
2020-01-15 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
GB0803352D0
(en)
*
|
2008-02-22 |
2008-04-02 |
Ntnu Technology Transfer As |
Oligopeptidic compounds and uses thereof
|
|
US9683031B2
(en)
|
2008-03-21 |
2017-06-20 |
Universiteit Hasselt |
Biomarkers for rheumatoid arthritis
|
|
US8058406B2
(en)
|
2008-07-09 |
2011-11-15 |
Biogen Idec Ma Inc. |
Composition comprising antibodies to LINGO or fragments thereof
|
|
CN102164611B
(en)
|
2008-07-24 |
2015-01-07 |
Ns基因公司 |
Therapeutic use of a growth factor, METRNL
|
|
DK2172211T3
(en)
|
2008-10-01 |
2015-02-16 |
Immatics Biotechnologies Gmbh |
Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
|
|
AU2009313808B2
(en)
|
2008-11-14 |
2013-05-16 |
Gen-Probe Incorporated |
Compositions, kits and methods for detection of campylobacter nucleic acid
|
|
US20110229471A1
(en)
|
2008-11-26 |
2011-09-22 |
Cedars-Sinai Medical Center |
Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
|
|
CA2745849A1
(en)
*
|
2008-12-09 |
2010-06-17 |
Alethia Biotherapeutics Inc. |
Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer
|
|
WO2010120830A1
(en)
|
2009-04-13 |
2010-10-21 |
Northwestern University |
Novel peptide-based scaffolds for cartilage regeneration and methods for their use
|
|
WO2011028952A1
(en)
|
2009-09-02 |
2011-03-10 |
Xencor, Inc. |
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
|
|
JP6210685B2
(en)
|
2010-01-27 |
2017-10-11 |
マサチューセッツ インスティテュート オブ テクノロジー |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
|
AU2011312417B2
(en)
|
2010-09-29 |
2015-08-20 |
Agensys, Inc. |
Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
|
|
CN103269708A
(en)
|
2010-10-01 |
2013-08-28 |
Ns基因公司 |
Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
|
|
WO2012081040A1
(en)
*
|
2010-12-14 |
2012-06-21 |
Hananja Ehf. |
Biological activity of placental protein 13
|
|
CN104105501B
(en)
|
2011-09-05 |
2017-10-20 |
霍巴治疗公司 |
Allodynia, hyperalgia, the treatment of spontaneous pain and phantom pain
|
|
AR088699A1
(en)
*
|
2011-11-09 |
2014-06-25 |
Sanofi Sa |
DIACILGLICEROL LIPASA AND USES OF THE SAME
|
|
CN108503711A
(en)
|
2012-04-30 |
2018-09-07 |
比奥孔有限公司 |
Targeting/immune regulative fusion protein and its manufacturing method
|
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
|
MX2014013950A
(en)
|
2012-05-14 |
2015-02-17 |
Biogen Idec Inc |
Lingo-2 antagonists for treatment of conditions involving motor neurons.
|
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
US10093736B2
(en)
|
2012-11-13 |
2018-10-09 |
Biontech Ag |
Agents for treatment of claudin expressing cancer diseases
|
|
WO2014127785A1
(en)
|
2013-02-20 |
2014-08-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
US9023353B2
(en)
*
|
2013-03-13 |
2015-05-05 |
The Board Of Trustees Of The University Of Arkansas |
Anti-(+)—methamphetamine monoclonal antibodies
|
|
WO2014146672A1
(en)
|
2013-03-18 |
2014-09-25 |
Ganymed Pharmaceuticals Ag |
Therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
EP2978440B1
(en)
|
2013-03-27 |
2019-10-02 |
Cedars-Sinai Medical Center |
Treating fibrosis by inhibiting tl1a and diagnosing fibrosis by detecting il31ra
|
|
JP7019233B2
(en)
|
2013-07-11 |
2022-02-15 |
モデルナティエックス インコーポレイテッド |
Compositions and Methods of Use Containing Synthetic polynucleotides and Synthetic sgRNAs Encoding CRISPR-Related Proteins
|
|
WO2015010108A1
(en)
|
2013-07-19 |
2015-01-22 |
Cedars-Sinai Medical Center |
Signature of tl1a (tnfsf15) signaling pathway
|
|
CN118146306A
(en)
|
2013-09-25 |
2024-06-07 |
西托姆克斯治疗公司 |
Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof
|
|
EP3053592A4
(en)
|
2013-10-01 |
2017-09-06 |
Mie University |
T cell-inducing vaccine containing interepitope sequence promoting antigen presentation
|
|
NZ722401A
(en)
|
2014-01-31 |
2023-06-30 |
Cytomx Therapeutics Inc |
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
|
|
MX2017009038A
(en)
|
2015-01-08 |
2017-10-25 |
Biogen Ma Inc |
Lingo-1 antagonists and uses for treatment of demyelinating disorders.
|
|
MA41374A
(en)
|
2015-01-20 |
2017-11-28 |
Cytomx Therapeutics Inc |
MATRIX METALLOPROTEASE CLIVABLE AND SERINE PROTEASE CLIVABLE SUBSTRATES AND METHODS OF USE THEREOF
|
|
US11124766B2
(en)
*
|
2015-06-12 |
2021-09-21 |
Emory University |
Growth and survival compositions for cells capable of producing antibodies and methods related thereto
|
|
EP3344776B1
(en)
*
|
2015-09-04 |
2021-06-16 |
Synthetic Genomics, Inc. |
Rekombinant algal microorganism with increased productivity
|
|
KR20240095481A
(en)
|
2016-03-17 |
2024-06-25 |
세다르스-신나이 메디칼 센터 |
Methods of diagnosing inflammatory bowel disease through rnaset2
|
|
CN109475624A
(en)
*
|
2016-03-29 |
2019-03-15 |
瓦尔基里治疗有限公司 |
The adjusting that the structure that chromosome -1 is expressed maintains
|
|
US9611297B1
(en)
|
2016-08-26 |
2017-04-04 |
Thrasos Therapeutics Inc. |
Compositions and methods for the treatment of cast nephropathy and related conditions
|
|
US11125757B2
(en)
|
2017-05-26 |
2021-09-21 |
Emory University |
Methods of culturing and characterizing antibody secreting cells
|
|
EP3508499A1
(en)
|
2018-01-08 |
2019-07-10 |
iOmx Therapeutics AG |
Antibodies targeting, and other modulators of, an immunoglobulin gene associated with resistance against anti-tumour immune responses, and uses thereof
|
|
KR20210102318A
(en)
|
2018-12-06 |
2021-08-19 |
싸이톰스 테라퓨틱스, 인크. |
Matrix metalloprotease-cleavable substrates and serine or cysteine protease-cleavable substrates and methods of use thereof
|
|
AU2020261435A1
(en)
*
|
2019-04-26 |
2021-11-25 |
Sangamo Therapeutics, Inc. |
Engineering AAV
|
|
CN114401992A
(en)
|
2019-07-05 |
2022-04-26 |
艾欧麦克斯治疗股份公司 |
Antibodies to IGSF11(VSIG3) that bind IGC2 and uses thereof
|
|
WO2021083958A1
(en)
*
|
2019-10-29 |
2021-05-06 |
Specialites Pet Food |
Novel peptides inducing satiety
|
|
AU2021244056B2
(en)
*
|
2020-03-27 |
2024-04-04 |
Onecuregen Co., Ltd. |
Composition comprising VGLL1 peptide for treatment of cancer
|
|
US20230212243A1
(en)
*
|
2020-05-12 |
2023-07-06 |
Institut Curie |
Neoantigenic Epitopes Associated with SF3B1 Mutations
|
|
US20240010720A1
(en)
|
2020-07-06 |
2024-01-11 |
Iomx Therapeutics Ag |
Antibodies binding igv of igsf11 (vsig3) and uses thereof
|
|
AU2022209669A1
(en)
*
|
2021-01-21 |
2023-08-10 |
Erasmus University Medical Center Rotterdam |
T cells for use in therapy
|
|
JP2024509376A
(en)
*
|
2021-02-18 |
2024-03-01 |
ベレン セラピューティクス ピー．ビー．シー． |
Treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrin
|
|
WO2023225602A1
(en)
*
|
2022-05-20 |
2023-11-23 |
Medikine, Inc. |
Interleukin-18 receptor binding polypeptides and uses thereof
|